The Pioneer Who Proved India Could Innovate: Ranjan Chakrabarti’s Journey From Us Consulate Reader to Biopharma Trailblazer
In the mid-1990s, suggesting that India could venture into original drug discovery research wasn’t just optimistic—it was laughable. The country’s pharmaceutical prowess rested entirely on reverse-engineering Western patents, manufacturing generics cheaply, and exporting to developing markets. Innovation? New chemical entities? Clinical trials meeting US FDA standards? These belonged to multinational pharmaceutical giants operating from gleaming […]




